The use of cannabis products and those containing cannabidiol (CBD) like delta 8 gummies and medical cannabis edibles are becoming increasingly popular, with people getting them online or at a cannabis dispensary and turning to them as possible treatments for pain, including pain caused by chronic illness. However, whether products are advertised as containing Δ9-tetrahydrocannabinol (THC) or CBD may not always be accurate, a study suggests.
“People are buying products they think are THC-free but in fact contain a significant amount of THC,” explained lead study author Jodi M. Gilman, PhD. “One patient reported that she took a product she thought only contained CBD, and then when driving home that day she felt intoxicated, disoriented and very scared.”
A study observed differences in the risk of new-onset dementia by gender and age among statin users with rheumatoid arthritis (RA).
Statin use was not correlated with the risk of new-onset dementia in the overall study population, but in subgroup analyses, statin use appeared to have a protective effect for certain patients with RA. Patients aged ≥60 years who were statin users, compared to non-statin users, had a lower risk of dementia. Also among patients aged ≥60 years, male statin users were less likely than female patients to develop dementia.
Finally, a study found that the Quit Connect protocol in rheumatology clinics is feasible and increases electronic referrals to a state-run tobacco quit line. “Rheumatology visits provide a unique opportunity to address smoking as a chronic modifiable risk factor in populations at high risk for cardiovascular disease, pulmonary disease, and rheumatic disease progression,” the authors write.
In Case You Missed It:
‘CBD-Dominant’ Products May Actually Contain THC
Statin Use May Decrease Dementia Risk in Certain Patients with RA
Protocol Ups Referrals to Tobacco Quit Line in Rheumatology Clinics
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.